1Alpert J S, Thygesen K, Antman E, et al. Myocardial infarction redefined--a consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction[J]. J Am Coil Cardiol,2000,36: 959-969.
2Babuin L, Jaffe A S. Troponin: the biomarker of choice for the detection of cardiac injury[J]. CMAJ,2005 ,173 :1191-1202.
3Mocelin A O, Issa V S, Bacal F, et al. The influence of aetiology on inflammatory and neurohumoral activation in patients with severe heart failure : a prospective study comparing Chagas' heart disease and idiopathic dilated cardiomyopathy[ J]. Eur J Heart Fail, 2005, 7: 869- 873.
4Finkelstein A, Michowitz Y, Abashidze A, et al. Temporal association between circulating proteolytic, inflammatory and neurohormonal markers in patients with coronary ectasia[ J]. Atherosclerosis,2005, 179:353-359.
5Karadag O, Calguneri M, Yavuz B, et al. B-type natriuretic peptide (BNP) levels in female systemic lupus erythernatosus patients: what is the clinical significance [ J ] ? Clin Rheumatol, 2007,216 : 1701 - 1704.
6Park M H, Uber P A, Scott R L, et al. B-type natriuretic peptide in heart transplantation: an important marker of allograft performance [J]. Heart Fail Rev,2003 ,8 :359-363.
7Pruszczyk P. N-terminal pro-brain natriuretic peptide as an indicator of right ventricular dysfunctian[ J]. J Card Fail,2005,11 (5 Suppl) : S65-69.
8Persu A, De Plaen J F. Recent insights in the development of organ damage caused by hypertension [ J ]. Acta Cardiol, 2004,59 : 369- 381.
9Burke M,A, Cotts W G. Interpretation of B-type natriuredc peptide in cardiac disease and other comorbid conditions[ J]. Heart Fail Rev, 2007, 12:23-36.
10Yap L B. B-type natriuretic peptide and the fight heart [ J ]. Heart Fail Rev ,2004,9:99-105.
